about
Leveraging electronic health record documentation for Failure Mode and Effects Analysis team identificationSuccessful combined liver-heart transplantation in adults: report of three patients and review of the literature.Slowing the progression of CHF. Drug therapy to correct neurohormonal abnormalities.Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.Contemporary use of beta receptor antagonists in chronic heart failure.Gene expression profiling to study racial differences after heart transplantationTreatment of hypertension in heart failure with preserved ejection fraction: role of the kidney.The sympathetic nervous system and heart failure.Balloon-expandable stent placement for superior vena cava-right atrial stenosis after heart transplantation.Reproducibility and observer variability of tissue phase mapping for the quantification of regional myocardial velocities.Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association.Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure.Invasive fungal infection after heart transplantation: A 7-year, single-center experience.A one-year comparison of prophylactic donor tricuspid annuloplasty in heart transplantation.Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction.Echocardiographic markers of left ventricular unloading using a centrifugal-flow rotary pump.Increased rejection rates in cardiac transplant associated with dexamethasone.Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics.The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapy.Prothrombin Complex Concentrate Reduces Blood Product Utilization in Heart Transplantation.Targeting the Correct Population When Designing Transitional Care Programs for Medicare Patients Hospitalized With Heart Failure.Treatment of left ventricular assist device thrombosis with extended catheter-directed intraventricular thrombolytic therapy.Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance.Diastolic coronary artery compression in a cardiac transplant recipient: treatment with a stent.Effectiveness of echocardiographic imaging by nurses to identify left ventricular systolic dysfunction in high-risk patients.Outpatient Use of Focused Cardiac Ultrasound to Assess the Inferior Vena Cava in Patients With Heart Failure.Geographic Variation in the Treatment of U.S. Adult Heart Transplant Candidates.Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosisTransapical approach for mitral valve repair during insertion of a left ventricular assist deviceCytomegalovirus infection in heart transplantation: A single center experienceImages in cardiovascular medicine. Carcinoid heart diseasePhysician-performed point-of-care echocardiography using a laptop platform compared with physical examination in the cardiovascular patientUse of 3-dimensional color Doppler echocardiography to measure stroke volume in human beings: comparison with thermodilutionAutomated border detection on contrast enhanced echocardiographic imagesPostoperative pericardial calcification causing diastolic coronary compressionPercutaneous transcatheter closure of the aortic valve to treat cardiogenic shock in a left ventricular assist device patient with severe aortic insufficiencyModified HeartMate II driveline externalization technique significantly decreases incidence of infection and improves long-term survivalIs it too early to investigate survival outcomes of the new US heart allocation system?Donor and Recipient Characteristics in Heart Transplantation Are Associated with Altered Myocardial Tissue Structure and Cardiac FunctionReply: Does Overtreatment of Heart Transplantation Candidates Exist?
P50
Q33564846-FC40DBDC-320E-423E-97BD-0159DEFBA850Q33779808-871E6493-4F53-4FB3-8259-6703CD48ED3FQ34193579-DA7216B7-89E2-4F24-8EF7-31194331FAC7Q34575166-40C33B00-7DEE-44E7-8FE1-1F9E42D4CD7DQ35036013-70D2D148-C3F4-4D7B-A4C7-48A252414E41Q35762677-519E4EF0-793D-4C1B-AF94-705A3A4B8B68Q37257365-80E24C32-726B-4B4F-BBD3-FFE8B20A819DQ38167053-4ABB57B0-2F06-4F4B-9125-3EC5D4094F40Q39427809-FD27EAC3-93EB-47E8-B316-91B36CA19852Q39820565-67B89B57-9D01-456D-A30E-6B4010CCDB10Q39828831-E1008482-E42E-4101-92B1-253A8D789219Q40355767-A1B9B7FA-0362-4A8F-9776-EFDEC321F855Q40413402-3BA2233C-5992-4A7B-9108-631975F13FD2Q43499287-44932CE9-741D-409F-9547-01AE26B88572Q43637988-61841CEA-12E9-44CD-86B5-56525B242E4FQ45275796-2E3C40E0-BA6D-43C7-9BD3-7A83BF9419C5Q46776292-3C2DAD2D-9050-4831-99F3-F2E8619F51A0Q46923746-0FD21DFC-3139-4986-8513-D254AC34F0C0Q47633655-267C18F6-43A1-458D-888E-83DF6C869D1BQ48601368-6AA97293-E161-4E41-8495-2801313C59FCQ49633706-8BF5FC66-5FC7-412E-AA44-3480F73555F1Q50973902-47FF9BF6-630E-48AE-8AF4-FFC608CE4980Q51005006-E60FA3B7-18CC-4388-9FA6-920A6EDBA5A6Q51466119-796A4B04-6F87-4950-95B6-31AD3694F603Q51475766-E12D4E37-17AB-4D63-8247-8473313EAA40Q51806758-9651AC53-DA29-43B4-B900-31ECF3472664Q55346792-5D0DC80B-B6DD-43C7-A4D8-9A1278D7DB0DQ58274881-5BFFE3C3-3046-470C-A07B-E7258F6E10B4Q59034798-B768C65B-06B7-4BAA-AD6F-948DDF3C67ACQ59349886-2398A9F9-CCFD-4834-9BC7-9F663F845164Q71047011-B3C4A984-66CB-41C9-AEF2-5719513B4291Q74070085-E9913E3B-DFA6-4644-B7A4-AA4FB801327AQ79715895-01356E46-FAC8-476C-B997-A5943FA6D116Q81007069-0EB0952A-459C-4DE0-AD98-FDFCB6C40C4CQ84790794-03F4292E-7368-4916-86F5-2F4B66E1440CQ84858402-23C47B9D-58B4-4932-AB66-3B3ECAA2D49BQ87464812-CE3A7FB3-32F7-48FD-849A-6834842636AEQ89615642-0845946F-06AD-4111-869D-E9BCD79A4059Q89794196-61C2D8F4-0055-4A19-896D-E3A09680685EQ90719138-D8AEFC47-719A-4F09-9AB6-8DAF407AE36A
P50
description
researcher
@en
wetenschapper
@nl
name
A S Anderson
@en
A S Anderson
@nl
type
label
A S Anderson
@en
A S Anderson
@nl
prefLabel
A S Anderson
@en
A S Anderson
@nl
P108
P106
P108
P31
P496
0000-0001-7216-2613